BC study reveals hidden mental-health burden linked to substance use

Incidence, prevalence and determinants of substance-induced mental disorders in British Columbia, 2022-2023: a population-based study.

Epidemiology and psychiatric sciences β€’ β€’ Relevant
πŸ€–

AI Summary

This population-based study examined substance-induced mental disorders (SIMDs) among British Columbia residents aged 12 and older during 2022–2023. Researchers identified 37,474 incident cases and 83,307 prevalent cases, equal to a cumulative incidence of 77.5 per 10,000 people and a prevalence of 171.4 per 10,000. Rates increased during 2023, reaching their highest reported levels in May 2023. Cases were more common among males and adults aged 25–44, with the greatest burden in Northern and Vancouver Island health authorities.

For cannabis users, the study found that cannabis-induced disordersβ€”along with hallucinogen-induced disordersβ€”were concentrated among younger people. However, the paper assessed substance-induced mental disorders broadly and does not establish that cannabis caused these conditions or compare cannabis risks directly with those of other substances. The findings highlight substantial healthcare use and show that many people with SIMD did not have a documented concurrent substance use disorder, supporting better screening and closer integration of mental-health and addiction care.

πŸ’‘ Key Findings

1
The study identified 37,474 incident and 83,307 prevalent substance-induced mental disorder cases in British Columbia over two years.
High
85%
2
SIMD rates rose through 2023, with the highest reported incidence (35.2 per 10,000) and prevalence (328.3 per 10,000) occurring in May 2023.
High
85%
3
Cannabis-induced disorders and hallucinogen-induced disorders were concentrated among younger people, while alcohol- and tobacco-related disorders were more common among older adults.
Good
75%
4
Fewer than one in five incident cases had a recorded concurrent substance use disorder, indicating that SIMD may frequently occur without a documented addiction diagnosis.
High
80%
5
The findings support improved detection and integrated psychiatric and addiction care, with prevention and treatment tailored to regional needs.
High
80%

πŸ“„ Original Abstract

Substance-induced mental disorders (SIMD) are an under-recognized consequence of psychoactive substance use, despite major implications for treatment needs, health service demand and outcomes. In the context of British Columbia's (BC's) ongoing toxic drug emergency, we aimed to (1) estimate the incidence and prevalence of SIMD in the provincial population and (2) describe socio-demographic, geographic, clinical and substance-specific patterns over a two-year period. We conducted a retrospective, population-based study using linked administrative health data from Population Data BC for residents aged ≥12 years between 1 January 2022 and 31 December 2023. SIMD cases were identified using a novel algorithm combining diagnostic codes with temporal linkage between substance-related events (poisoning, withdrawal or substance use disorder) and subsequent psychiatric diagnoses. Incident cases had no record of the same mental disorder in the previous two years; prevalent cases met SIMD criteria at any point in the study period. We calculated monthly, annual and cumulative incidence and prevalence rates per 10,000 population, stratified by sex, age group, health authority, urban/rural residence, neighbourhood income, psychiatric diagnosis, substance class, concurrent substance use disorder, involuntary treatment and mortality. We identified 37,474 incident and 83,307 prevalent SIMD cases over two years, corresponding to a cumulative incidence of 77.5 and prevalence of 171.4 per 10,000 population. Monthly rates fluctuated in 2022, followed by a rise through 2023, with highest incidence (35.2 per 10,000) and prevalence (328.3 per 10,000) in May 2023. Males accounted for 62% of incident and 59% of prevalent cases; mean age was 43 years, with highest proportions in the 25-44 age range. Northern and Vancouver Island Health Authorities had the greatest burden. On average, individuals with SIMD had 3.2-3.6 healthcare visits per month. Cannabis- and hallucinogen-induced disorders were concentrated among younger people, while alcohol- and tobacco-related SIMD predominated in older adults; stimulant-related SIMD showed the highest hospitalization and involuntary treatment rates. Only about one-third of prevalent and fewer than one in five incident cases had a recorded concurrent substance use disorder. SIMDs are common, clinically complex and unevenly distributed across demographic and geographic groups in BC. The high rates, substantial service use and frequent occurrence outside documented substance use disorder diagnoses underscore the need for improved detection of SIMD, integration of psychiatric and addiction care and regionally tailored prevention and treatment strategies within the ongoing toxic drug emergency.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.